Making the Most of Monoclonal Antibodies: Genmab Gunning for Blockbuster

ISSN： 1176-3469

Source： Pharmaceutical & Diagnostic Innovation, Vol.4, Iss.11, 2006-01, pp. : 10-12

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Monoclonal antibodies

By Drakeman D.L. Wallace P.K.

Expert Opinion on Emerging Drugs, Vol. 4, Iss. 1, 1999-01 ,pp. : 355-365

Informa Healthcare

Access to resources Recommend Favorite

Radiolabelled Peptides and Monoclonal Antibodies for Therapy Decision Making in Inflammatory Diseases

Current Pharmaceutical Design, Vol. 14, Iss. 24, 2008-08 ,pp. : 2401-2414

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Receptor Tyrosine Kinases Using Monoclonal Antibodies: The Most Specific Tools for Targeted-Based Cancer Therapy

Current Drug Targets, Vol. 17, Iss. 14, 2016-11 ,pp. : 1687-1703

Bentham Science Publishers

Access to resources Recommend Favorite

Monoclonal Antibodies in Solid Tumours

Current Clinical Pharmacology, Vol. 5, Iss. 3, 2010-08 ,pp. : 160-165

Bentham Science Publishers

Access to resources Recommend Favorite

Monoclonal Antibodies - Regulatory Challenges

Current Pharmaceutical Biotechnology, Vol. 9, Iss. 6, 2008-12 ,pp. : 431-438

Bentham Science Publishers

Access to resources Recommend Favorite